ETF Holdings Breakdown of DOCS

Stock Name	Dr. Martens PLC
Ticker	DOCS(GBX) LSE
TYPE	Common Stock
Country	UK
ISIN	GB00BL6NGV24
LEI	213800QPT8YM6NQZPH28

DOCS institutional holdings

The following institutional investment holdings of DOCS have been identified

Date ETF ISIN/Name Num Shares Book value
2025-09-18 IE000NITTFF2 (iShares Russell 1000 Growth UCITS ETF) 1,970 USD 144,992 1.3%

Total = 1,970 USD 144,992
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-18	IE000NITTFF2 (iShares Russell 1000 Growth UCITS ETF)	1,970	USD 144,992 1.3%
Total =	1,970	USD 144,992

News associated with DOCS

Giles Wilson Acquires 167 Shares of Dr. Martens (LON:DOCS) Stock: Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson acquired 167 shares of the firm’s stock in a transaction that occurred on Thursday, September 11th. The stock was acquired at an average price of GBX 90 per share, for a total transaction of £150.30. Giles Wilson also recently made the following trade(s): On […] - 2025-09-18 02:06:54
Dr. Martens (LON:DOCS) Hits New 12-Month High – Here’s What Happened: Dr. Martens plc (LON:DOCS – Get Free Report) shares reached a new 52-week high during trading on Monday . The stock traded as high as GBX 96.50 ($1.31) and last traded at GBX 91.80 ($1.24), with a volume of 2227395 shares traded. The stock had previously closed at GBX 92 ($1.25). Analyst Upgrades and Downgrades […] - 2025-09-15 05:12:48
Dr. Martens (LON:DOCS) Raised to “Buy” at Peel Hunt: Dr. Martens (LON:DOCS – Get Free Report) was upgraded by equities researchers at Peel Hunt to a “buy” rating in a report released on Monday, MarketBeat.com reports. A number of other research analysts also recently issued reports on DOCS. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Dr. Martens in a report on […] - 2025-08-21 02:57:16
Dr. Martens (LON:DOCS) Sets New 52-Week High Following Analyst Upgrade: Dr. Martens plc (LON:DOCS – Get Free Report) shares hit a new 52-week high on Tuesday after Peel Hunt upgraded the stock to a buy rating. The company traded as high as GBX 86 ($1.16) and last traded at GBX 85.54 ($1.15), with a volume of 1096627 shares. The stock had previously closed at GBX […] - 2025-08-21 02:25:49
Doximity, Inc. (NASDAQ:DOCS) Stake Cut by Swiss National Bank: Swiss National Bank lessened its position in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 4.8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 211,000 shares of the company’s stock after selling 10,600 shares during the period. Swiss National Bank owned […] - 2025-08-15 05:24:50
Giles Wilson Buys 194 Shares of Dr. Martens plc (LON:DOCS) Stock: Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson bought 194 shares of the business’s stock in a transaction on Monday, August 11th. The stock was purchased at an average cost of GBX 77 ($1.05) per share, with a total value of £149.38 ($202.85). Giles Wilson also recently made the following trade(s): On […] - 2025-08-14 02:16:57
Dr. Martens plc (LON:DOCS) Insider Buys £149.38 in Stock: Dr. Martens plc (LON:DOCS – Get Free Report) insider Ije Nwokori purchased 194 shares of the stock in a transaction dated Monday, August 11th. The shares were bought at an average price of GBX 77 ($1.04) per share, for a total transaction of £149.38 ($201.67). Ije Nwokori also recently made the following trade(s): On Friday, […] - 2025-08-13 02:18:46
Doximity (NASDAQ:DOCS) Stock Price Down 6.5% Following Insider Selling: Doximity, Inc. (NASDAQ:DOCS – Get Free Report)’s share price was down 6.5% during mid-day trading on Monday following insider selling activity. The company traded as low as $62.43 and last traded at $62.28. Approximately 1,810,206 shares traded hands during mid-day trading, a decline of 23% from the average daily volume of 2,363,053 shares. The stock […] - 2025-08-12 02:34:43
Doximity (NASDAQ:DOCS) Price Target Raised to $59.00: Doximity (NASDAQ:DOCS – Free Report) had its price objective upped by Canaccord Genuity Group from $50.00 to $59.00 in a report issued on Friday morning,Benzinga reports. Canaccord Genuity Group currently has a hold rating on the stock. Other equities analysts have also recently issued research reports about the stock. Mizuho cut their target price on […] - 2025-08-11 05:06:50
Natixis Advisors LLC Acquires 6,341 Shares of Doximity, Inc. (NASDAQ:DOCS): Natixis Advisors LLC boosted its holdings in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 17.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 42,223 shares of the company’s stock after purchasing an additional 6,341 shares during the quarter. […] - 2025-08-08 05:22:58
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.56 Million in Doximity, Inc. (NASDAQ:DOCS): Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Doximity, Inc. (NASDAQ:DOCS – Free Report) during the first quarter, HoldingsChannel reports. The institutional investor acquired 61,291 shares of the company’s stock, valued at approximately $3,557,000. Other large investors have also recently made changes to their positions in the company. Ballentine Partners LLC bought a […] - 2025-07-29 05:23:03
Cwm LLC Increases Stock Holdings in Doximity, Inc. (NASDAQ:DOCS): Cwm LLC lifted its position in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 53.0% in the first quarter, HoldingsChannel reports. The firm owned 7,415 shares of the company’s stock after buying an additional 2,569 shares during the period. Cwm LLC’s holdings in Doximity were worth $430,000 at the end of the most recent quarter. Other […] - 2025-07-25 05:09:06
Stephens Inc. AR Has $252,000 Position in Doximity, Inc. (NASDAQ:DOCS): Stephens Inc. AR reduced its position in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 6.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,344 shares of the company’s stock after selling 318 shares during the period. Stephens Inc. AR’s […] - 2025-07-21 05:10:47
3,461 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Ballentine Partners LLC: Ballentine Partners LLC purchased a new position in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) during the first quarter, Holdings Channel reports. The firm purchased 3,461 shares of the company’s stock, valued at approximately $201,000. Other institutional investors and hedge funds have also recently bought and sold shares of the company. Wealth Enhancement Advisory […] - 2025-07-18 09:22:56
Alps Advisors Inc. Lowers Stock Position in Doximity, Inc. (NASDAQ:DOCS): Alps Advisors Inc. lessened its stake in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 36.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,756 shares of the company’s stock after selling 3,321 shares during the period. Alps Advisors Inc.’s holdings in Doximity were […] - 2025-07-18 06:22:45
Arizona State Retirement System Decreases Position in Doximity, Inc. (NASDAQ:DOCS): Arizona State Retirement System decreased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 4.4% during the first quarter, HoldingsChannel reports. The institutional investor owned 31,242 shares of the company’s stock after selling 1,450 shares during the period. Arizona State Retirement System’s holdings in Doximity were worth $1,813,000 at the end of […] - 2025-07-18 05:13:11
Xponance Inc. Purchases 747 Shares of Doximity, Inc. (NASDAQ:DOCS): Xponance Inc. grew its stake in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 4.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,054 shares of the company’s stock after acquiring an additional 747 shares during the […] - 2025-07-17 05:30:57
Giles Wilson Purchases 194 Shares of Dr. Martens plc (LON:DOCS) Stock: Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson bought 194 shares of Dr. Martens stock in a transaction that occurred on Friday, July 11th. The shares were acquired at an average price of GBX 77 ($1.03) per share, with a total value of £149.38 ($200.00). Giles Wilson also recently made the following […] - 2025-07-16 02:21:28
Dr. Martens plc (LON:DOCS) Insider Purchases £149.38 in Stock: Dr. Martens plc (LON:DOCS – Get Free Report) insider Ije Nwokori acquired 194 shares of Dr. Martens stock in a transaction on Friday, July 11th. The shares were purchased at an average cost of GBX 77 ($1.03) per share, for a total transaction of £149.38 ($200.00). Ije Nwokori also recently made the following trade(s): On […] - 2025-07-16 02:21:28
State of Michigan Retirement System Raises Stock Holdings in Doximity, Inc. (NASDAQ:DOCS): State of Michigan Retirement System boosted its position in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 5.6% in the 1st quarter, HoldingsChannel reports. The firm owned 32,000 shares of the company’s stock after purchasing an additional 1,700 shares during the period. State of Michigan Retirement System’s holdings in Doximity were worth $1,857,000 at the end […] - 2025-07-15 07:02:50
Doximity (NASDAQ:DOCS) Price Target Raised to $70.00: Doximity (NASDAQ:DOCS – Free Report) had its price target raised by KeyCorp from $65.00 to $70.00 in a report issued on Monday,Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other research analysts have also recently commented on the company. The Goldman Sachs Group set a $50.00 price target […] - 2025-07-15 06:21:05
Axxcess Wealth Management LLC Buys New Stake in Doximity, Inc. (NASDAQ:DOCS): Axxcess Wealth Management LLC purchased a new position in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 4,384 shares of the company’s stock, valued at approximately $254,000. Other institutional investors have also modified their holdings of […] - 2025-07-14 06:18:54
Insider Selling: Doximity, Inc. (NASDAQ:DOCS) Director Sells $300,200.00 in Stock: Doximity, Inc. (NASDAQ:DOCS – Get Free Report) Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction dated Friday, July 11th. The shares were sold at an average price of $60.04, for a total transaction of $300,200.00. Following the sale, the director owned 16,618 shares in the company, valued at approximately $997,744.72. […] - 2025-07-14 05:38:48
Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Principal Financial Group Inc.: Principal Financial Group Inc. boosted its stake in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 4.5% in the 1st quarter, Holdings Channel reports. The fund owned 307,097 shares of the company’s stock after buying an additional 13,123 shares during the period. Principal Financial Group Inc.’s holdings in Doximity were worth $17,821,000 as of […] - 2025-07-11 05:21:04
D.A. Davidson & CO. Raises Stock Position in Doximity, Inc. (NASDAQ:DOCS): D.A. Davidson & CO. raised its holdings in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 1.7% in the first quarter, Holdings Channel.com reports. The institutional investor owned 21,574 shares of the company’s stock after purchasing an additional 365 shares during the quarter. D.A. Davidson & CO.’s holdings in Doximity were worth $1,252,000 at […] - 2025-07-09 05:53:10
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by KBC Group NV: KBC Group NV cut its position in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 92.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,273 shares of the company’s stock after selling 68,250 shares during the period. KBC Group NV’s holdings […] - 2025-07-06 05:37:05
Amalgamated Bank Grows Holdings in Doximity, Inc. (NASDAQ:DOCS): Amalgamated Bank increased its stake in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 0.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 60,928 shares of the company’s stock after purchasing an additional 186 shares during the period. Amalgamated Bank’s holdings in Doximity were worth […] - 2025-07-04 05:58:54
Perigon Wealth Management LLC Has $408,000 Position in Doximity, Inc. (NASDAQ:DOCS): Perigon Wealth Management LLC cut its holdings in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 22.5% in the 1st quarter, HoldingsChannel.com reports. The fund owned 7,027 shares of the company’s stock after selling 2,039 shares during the period. Perigon Wealth Management LLC’s holdings in Doximity were worth $408,000 at the end of the most recent […] - 2025-07-01 05:14:55
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Creative Financial Designs Inc. ADV: Creative Financial Designs Inc. ADV decreased its holdings in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 40.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,130 shares of the company’s stock after selling 1,450 shares during the quarter. Creative Financial Designs Inc. ADV’s […] - 2025-06-30 06:16:43
Doximity, Inc. (NASDAQ:DOCS) Director Regina M. Benjamin Sells 10,000 Shares: Doximity, Inc. (NASDAQ:DOCS – Get Free Report) Director Regina M. Benjamin sold 10,000 shares of Doximity stock in a transaction that occurred on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the transaction, the director now owns 16,618 shares in the company, valued […] - 2025-06-30 05:41:03

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.